Lixazinone stimulates mitogenesis of madin-darby canine kidney cells

Experimental Biology and Medicine

Volumn 231, Issue 3, 2006, Pages 288-295

  Cheng, Jingfei ^a   Thompson, Michael A ^a   Walker, Henry J ^a   Gray, Catherine E ^a   Warner, Gina M ^a   Zhou, Wei ^a   Grande, Joseph P ^a  

^a Mayo Clinic   (United States)

Author keywords

B Raf; cAMP; MAPK; MDCK; PKD

Indexed keywords

B RAF KINASE; CYCLIC AMP; CYCLIN D; CYCLIN E; HISTONE H1 KINASE; LIXAZINONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; PROTAMINE KINASE; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELL TYPE; DOG; ENZYME ACTIVATION; ENZYME ASSAY; HYDROLYSIS; IN VITRO STUDY; KIDNEY CELL; MITOGENESIS; NONHUMAN;

ANIMALIA; CANIS FAMILIARIS;

EID: 33644692044     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100308     Document Type: Article

References (46)

1. Murcia N, Sweeney WJ, Avner E. New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55:1187-1197, 1999.
2. Wellig L, Grantham J. Cystic and developmental diseases of the kidney. In: Brenner B, Ed. The Kidney. Philadelphia, WB Saunders Co, Vol 2:pp1828-1863, 1996.
3. Gabow PA. Polycystic kidney disease: clues to pathogenesis. Kidney Int 40:989-996, 1991.
4. Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham J. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 20:703-709, 1997.
5. Grantham JJ. Renal cell proliferation and the two faces of cyclic adenosine monophosphate. J Lab Clin Med 130:459-460, 1997.
6. Mangoo-Karim R, Uchic M, Lechene C, Grantham J. Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci U S A 86:6007-6011, 1989.
7. McCaffrey TA, Du B, Consigli S, Szabo P, Bray PJ, Hartner L, Weksler BB, Sanborn TA, Bergman G, Bush HL. Genomic instability in the type II TGF-b1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest 100:2182-2188, 1997.
8. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem 271:505-511, 1996.
9. Erhardt P, Troppmair J, Rapp R, Cooper G. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15:5524-5530, 1995.
10. Beavo J. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748, 1995.
11. Dousa T. Cyclic-3′, 5′-nucleotide phosphodiesterase isozymes in cell biology and pathobiology of the kidney. Kidney Int 55:29-62, 1999.
12. Sonnenburg WK, Beavo JA. Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv Pharmacol 26:87-114, 1994.
13. Conti M, Nemoz G, Sette C, Vicini E. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr Rev 16:370-389, 1995.
14. Manganiello VC, Murata T, Taira M, Belfrage P, Degerman E. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch Biochem Biophys 322:1-13, 1995.
15. Chini CCS, Grande JP, Chini EN, Dousa TP. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. J Biol Chem 272:9854-9859, 1997.
16. Matousovic K, Tsuboi Y, Walker H, Grande JP, Dousa TP. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. J Lab Clin Med 130:487-495, 1997.
17. Cheng J, Thompson MA, Walker HJ, Gray CE, Diaz Encarnacion MM, Warner GM, Grande JP. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4. Am J Physiol Renal Physiol 287:F940-F953, 2004.
18. Grande JP, Jones ML, Swenson CL, Killen PD, Warren JS. Lipopolysaccharide induces monocyte chemoattractant protein production by rat mesangial cells. J Lab Clin Med 124:112-117, 1994.
19. Chini CCS, Chini EN, Williams JM, Matousovic K, Dousa TP. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney Int 46:28-36, 1994.
20. Yamaki M, McIntyre S, Rassier ME, Schwartz JH, Dousa TP. Cyclic 3′,5′-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells. Am J Physiol 262:F957-F964, 1992.
21. Lowry O, Rosebrough A, Farr A, Randall R. Protein measurement with folin phenol reagent. J Biol Chem 193:265-275, 1951.
22. Dumont JE, Jauniaux JC, Roger PP. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67-71, 1989.
23. Frodin M, Peraldi P, Van Obberghen E. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269:6207-6214, 1994.
24. Sherr CJ. G1 phase progression: cycling on cue. Cell 79:551-555, 1994.
25. Sherr CJ. Mammalian G1 cyclins. Cell 73:1059-1065, 1993.
26. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266, 2002.
27. Chini E, Chini C, Bollinger C, Jougasaki M, Grande J, Burnett J, Dousa T. Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int 52:917-925, 1997.
28. Matousovic K, Grande JP, Chini CCS, Chini EN, Dousa TP. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J Clin Invest 96:401-410, 1995.
29. Hida M, Fujita H, Ishikura K, Omori S, Hoshiya M, Awazu M. Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-beta in mesangial cells. J Cell Physiol 196:293-300, 2003.
30. Mangoo-Karim R, Uchic M, Grant M, Shumate W, Calvet J, Park C, Grantham J. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J 3:2629-2632, 1989.
31. Belibi FA, Wallace DP, Yamaguchi T, Christensen M, Reif G, Grantham JJ. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13:2723-2729, 2002.
32. Yamaguchi T, Pelling J, Ramaswamy N, Eppler J, Wallace D, Nagao S, Rome L, Sullivan L, Grantham J. Cyclic AMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57:1460-1471, 2000.
33. Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin TA, Lawrence JC, Jr. cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci U S A 92:7222-7226, 1995.
34. Jones ML, Warren JS. Monocyte chemoattractant protein 1 in a rat model of pulmonary granulomatosis. Lab Invest 66:498-503, 1992.
35. Wolf G, Neilson EG. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39:401-420, 1991.
36. Ekblom P, Weller A. Ontogeny of tubulointerstitial cells. Kidney Int 39:394-400, 1991.
37. Santiago A, Satriano J, DeCandido S, Holthofer H, Schreiber R, Unkeless J, Schlondorff D. A specific Fc-gamma receptor on cultured rat mesangial cells. J Immunol 143:2575-2582, 1989.
38. Lee TH, Chuang LY, Hung WC. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 19:3766-3773, 2000.
39. van Oirschot BA, Stahl M, Lens SM, Medema RH. Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem 276:33854-33860, 2001.
40. L'Allemain G, Lavoie JN, Rivard N, Baldin V, Pouyssegur J. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14:1981-1990, 1997.
41. Kitagawa M, Higashi H, Jung H, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y. The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclin A/E-cdk2. EMBO J 15:7060-7069, 1996.
42. Lundberg A, Weinberg R. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclincdk complexes. Mol Cell Biol 18:753-761, 1998.
43. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ. Changes in cellcycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239, 1996.
44. Kip1. Kidney Int 51:1088-1099, 1997.
45. Kim YG, Alpers CE, Brugarolas J, Johnson RJ, Couser WG, Shankland SJ. The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 55:2349-2361, 1999.
46. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13:65-70, 2003.